ISISPHARMA GLYCO-A PEELING CREAM 30ML
A professional‑inspired peeling cream formulated to help improve skin texture and clarity. It supports gentle exfoliation for smoother, more radiant‑looking skin when used as part of a regular skincare routine.
19.55 د.ا
In stock
Add to wishlist Add to compareAsk about productDescription
ISISPHARMA GLYCO‑A PEELING CREAM 30ML is a scientifically formulated exfoliating cream designed to support the removal of dead skin cells and help improve skin surface texture. Enriched with glycolic acid, this peeling cream works to gently promote skin renewal, supporting a clearer, more refined complexion.
The cream’s balanced formulation provides effective exfoliation while helping to maintain skin hydration and comfort. With consistent use, it contributes to a smoother feel and a visibly more even skin tone, making it suitable for individuals seeking enhanced texture and glow. Ideal for evening application in a structured skincare routine, this peeling cream helps reveal fresher, more luminous skin.
Key Benefits:
- Helps support skin exfoliation and renewal
- Contributes to smoother, refined skin texture
- Supports improved skin clarity and radiance
- Balanced formula that helps maintain hydration
- Suitable for incorporation into regular skincare routines
Product Information:
- Product Name: ISISPHARMA GLYCO‑A PEELING CREAM 30ML
- Category: Skincare – Exfoliating / Peeling Cream
- Problem it solves: Rough texture, dull complexion, uneven surface
- Key benefits: Exfoliation support, smoother skin, enhanced radiance, texture refinement
- Ingredients or features: Glycolic acid, hydrating agents, balanced peeling formulation
- How to use: Apply a thin layer to clean, dry skin in the evening. Avoid contact with eyes. Use sunscreen during the day. Adjust frequency based on skin tolerance.
- Target audience: Individuals seeking texture improvement and exfoliating care
- Requirements: External use only. Avoid broken skin. Patch test recommended before first use.







Reviews
There are no reviews yet.